Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 82 | 87 | 118 | 79 | 107 | 103 | 167 | 120 | 145 | 161 | 213 | 228 |
| Expenses | 72 | 76 | 107 | 68 | 93 | 89 | 150 | 103 | 123 | 135 | 184 | 195 |
| Operating Profit | 10 | 11 | 11 | 10 | 14 | 13 | 17 | 17 | 22 | 26 | 29 | 33 |
| OPM % | 12% | 12% | 9% | 13% | 13% | 13% | 10% | 14% | 15% | 16% | 14% | 14% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 3 | 4 | 4 | 4 | 5 | 5 | 8 | 7 | 8 | 11 | 14 | 9 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 4 |
| Profit before tax | 6 | 6 | 6 | 6 | 8 | 7 | 8 | 9 | 13 | 14 | 12 | 21 |
| Tax % | 32% | 27% | 13% | 25% | 44% | 25% | 12% | 25% | 25% | 25% | 4% | 36% |
| Net Profit | 4 | 4 | 5 | 4 | 4 | 5 | 7 | 7 | 10 | 10 | 11 | 13 |
| EPS in Rs | 2.79 | 2.99 | 3.59 | 2.91 | 3.01 | 3.75 | 4.98 | 4.77 | 6.85 | 6.51 | 6.75 | 7.98 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 42 | 57 | 60 | 97 | 113 | 134 | 222 | 275 | 348 | 454 | 635 | 748 |
| Expenses | 38 | 53 | 54 | 87 | 104 | 126 | 208 | 247 | 310 | 401 | 544 | 637 |
| Operating Profit | 4 | 3 | 6 | 10 | 8 | 8 | 14 | 28 | 38 | 53 | 91 | 111 |
| OPM % | 9% | 6% | 10% | 11% | 7% | 6% | 6% | 10% | 11% | 12% | 14% | 15% |
| Other Income | 1 | 2 | 0 | 0 | 1 | 1 | 2 | 2 | 1 | 2 | 4 | 0 |
| Interest | 2 | 2 | 2 | 3 | 4 | 4 | 5 | 9 | 14 | 22 | 39 | 41 |
| Depreciation | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 3 | 4 | 4 | 8 | 10 |
| Profit before tax | 2 | 2 | 3 | 6 | 2 | 3 | 9 | 18 | 21 | 28 | 48 | 59 |
| Tax % | 42% | 36% | 34% | 28% | 24% | 37% | 26% | 38% | 27% | 26% | 30% | |
| Net Profit | 1 | 1 | 2 | 4 | 2 | 2 | 6 | 11 | 16 | 21 | 33 | 44 |
| EPS in Rs | 1.51 | 2.01 | 1.70 | 3.72 | 1.58 | 1.68 | 4.77 | 7.95 | 11.08 | 14.65 | 20.25 | 28.09 |
| Dividend Payout % | 13% | 10% | 12% | 6% | 14% | 14% | 5% | 3% | 2% | 2% | 1% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 31% | 37% | 32% | 50% | ||
| Compounded Profit Growth | 40% | 75% | 45% | 90% | ||
| Stock Price CAGR | 67% | 52% | 65% | 219% | ||
| Return on Equity | 14% | 15% | 15% | 16% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2 | 2 | 2 | 3 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 |
| Reserves | 0 | 1 | 2 | 19 | 35 | 37 | 39 | 64 | 92 | 117 | 137 | 273 |
| Borrowings | 9 | 16 | 21 | 10 | 19 | 35 | 40 | 53 | 87 | 106 | 166 | 222 |
| Other Liabilities | 11 | 24 | 30 | 47 | 47 | 65 | 79 | 66 | 74 | 81 | 179 | 141 |
| Total Liabilities | 23 | 43 | 56 | 79 | 105 | 141 | 162 | 187 | 257 | 308 | 487 | 642 |
| Fixed Assets | 8 | 15 | 16 | 16 | 31 | 31 | 30 | 32 | 39 | 47 | 53 | 118 |
| CWIP | 1 | 0 | 4 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 |
| Other Assets | 14 | 29 | 36 | 52 | 74 | 110 | 131 | 155 | 218 | 260 | 433 | 522 |
| Total Assets | 23 | 43 | 56 | 79 | 105 | 141 | 162 | 187 | 257 | 308 | 487 | 642 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 2 | 3 | 4 | 17 | 1 | -11 | 0 | -2 | -14 | -0 | -21 | 16 |
| Cash from Investing Activity | -3 | -6 | -7 | -8 | -5 | -1 | -1 | -4 | -9 | -8 | -6 | -74 |
| Cash from Financing Activity | 1 | 3 | 3 | -8 | 4 | 14 | -1 | 7 | 25 | 6 | 26 | 122 |
| Net Cash Flow | 0 | 1 | -1 | 1 | 0 | 2 | -2 | 1 | 1 | -2 | -1 | 65 |
| Free Cash Flow | -1 | -3 | -3 | 9 | -4 | -12 | -1 | -7 | -24 | -8 | -27 | -57 |
| CFO/OP | 108% | 85% | 117% | 303% | 8% | -128% | 2% | -17% | -52% | -1% | -43% | 18% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 75 | 98 | 131 | 94 | 67 | 126 | 112 | 148 | 46 | 68 | 142 | 53 |
| Inventory Days | 102 | 140 | 68 | 170 | 249 | 227 | 242 | 96 | 264 | 246 | 267 | 219 |
| Days Payable | 167 | 221 | 224 | 360 | 205 | 208 | 215 | 101 | 104 | 88 | 161 | 71 |
| Cash Conversion Cycle | 11 | 17 | -24 | -96 | 110 | 145 | 139 | 144 | 205 | 225 | 248 | 201 |
| Working Capital Days | -54 | -44 | -39 | 42 | 66 | 65 | 116 | 126 | 97 | 92 | 76 | 79 |
| ROCE % | 14% | 25% | 18% | 16% | 21% | 10% | 10% | 13% | 18% | 17% | 19% | 21% |
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Jul 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 49.16% | 49.17% | 49.17% | 48.93% | 48.93% | 48.93% | 48.93% | 48.93% | 43.06% | 44.17% | 44.57% | 44.57% |
| FIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.01% | 0.46% | 1.06% | 1.06% | 1.06% |
| DIIs | 1.60% | 1.60% | 1.60% | 1.59% | 1.59% | 1.59% | 1.59% | 1.61% | 3.48% | 2.83% | 2.94% | 2.94% |
| Public | 49.24% | 49.24% | 49.23% | 49.47% | 49.47% | 49.47% | 49.49% | 49.46% | 53.00% | 51.94% | 51.45% | 51.43% |
| No. of Shareholders | 6,837 | 7,507 | 7,511 | 8,018 | 8,121 | 7,976 | 7,906 | 8,120 | 8,765 | 8,338 | 8,903 | 9,598 |
Fundamentals
Market Cap₹ 2,301 Cr.
Current Price₹ 1,392
Stock P/E51.8
Book Value₹ 170
ROCE21.5 %
ROE15.8 %
Dividend Yield0.02 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)50%
Compounded Profit Growth (TTM)90%
Standalone figures.
Valuation
Market capRs 2,240 Cr
Enterprise valueRs 2,397 Cr
P/E (TTM)50.39x
Price to book8.04x
Price to sales3.00x
EV / EBITDA21.67x
EV / EBIT23.84x
EV / sales3.21x
Price to cash flow136.24x
Earnings yield1.98%
Dividend yield0.02%
P/E, 3-year average7.14x
P/B, 3-year average0.92x
P/E, 5-year average10.73x
P/B, 5-year average1.19x
Profitability
Operating margin (excl. other income)14.34%
Operating margin (incl. other income)14.92%
EBITDA margin14.79%
Pre-tax margin7.91%
Net profit margin5.95%
Net margin, latest quarter5.77%
ROE15.81%
ROCE21.49%
ROA5.88%
ROE, 3-year average15.33%
ROCE, 3-year average19.19%
ROA, 3-year average5.55%
ROE, 5-year average14.11%
ROCE, 5-year average17.66%
ROA, 5-year average5.03%
ROIC (approx.)16.10%
Tax rate30.20%
Other income / net worth1.31%
Growth
Sales growth (latest year)40.03%
Profit growth (latest year)59.59%
Sales CAGR, 3 years32.26%
Sales CAGR, 5 years36.54%
Profit CAGR, 3 years45.37%
Profit CAGR, 5 years75.23%
Sales growth QoQ7.13%
Profit growth QoQ18.97%
Sales growth YoY (latest quarter)90.45%
Profit growth YoY (latest quarter)94.53%
Per share
EPS (TTM)Rs 26.89
EPS (latest year)Rs 60.68
EPS (latest quarter)Rs 7.97
EPS, 3-year averageRs 46.00
EPS, 5-year averageRs 35.23
Book value per shareRs 168.62
Sales per shareRs 452.28
Cash flow per shareRs 9.95
Free cash flow per shareRs -34.49
Dividend per share (latest year)Rs 0.69
Dividend per share, 3-year averageRs 0.70
Dividend per share, 5-year averageRs 0.70
Dividends
Dividend payout1.14%
Dividend payout, 3-year average1.61%
Dividend payout, 5-year average2.54%
Efficiency
Asset turnover0.99x
Fixed asset turnover5.37x
Inventory turnover1.75x
Inventory days209 days
Debtor days53 days
Debtors turnover6.86x
Creditor days71 days
Cash conversion cycle201 days
Working capital days79 days
Leverage
Total debtRs 222 Cr
Cash and bankRs 65 Cr
Net debtRs 157 Cr
Debt to equity0.80x
Net debt / EBITDA1.42x
Interest coverage2.43x
Owners' fund to total sources43.40%
Debt to assets34.58%
Cash flow
Cash from Operating Activity (latest year)Rs 16 Cr
Cash from Investing Activity (latest year)Rs -74 Cr
Cash from Financing Activity (latest year)Rs 122 Cr
Net Cash Flow (latest year)Rs 65 Cr
Free cash flow (latest year)Rs -57 Cr
FCFE (approx.: FCF + change in debt)Rs -1 Cr
Cash from ops / profit, 5 years-0.24x
Sales to cash flow38.65x
Statement figures
Net sales (TTM)Rs 748 Cr
Net sales (latest year)Rs 635 Cr
Sales (latest quarter)Rs 228 Cr
Operating profit excl. other income (latest year)Rs 91 Cr
Operating profit (latest quarter)Rs 33 Cr
Other income (TTM)Rs 4 Cr
EBITDA (TTM)Rs 111 Cr
PBDT (TTM)Rs 69 Cr
Profit before tax (TTM)Rs 59 Cr
Tax (latest year)Rs 14 Cr
Net profit (TTM)Rs 44 Cr
Net profit (latest year)Rs 33 Cr
Net profit (latest quarter)Rs 13 Cr
Depreciation (TTM)Rs 10 Cr
Depreciation (latest quarter)Rs 4 Cr
Interest (TTM)Rs 41 Cr
Cost of goods sold (latest year)Rs 472 Cr
Total expenditure (latest year)Rs 544 Cr
Total income (latest year)Rs 639 Cr
Share capitalRs 5 Cr
ReservesRs 273 Cr
Shareholders' fundsRs 279 Cr
Total assetsRs 642 Cr
Net blockRs 118 Cr
InvestmentsRs 2 Cr
ReceivablesRs 93 Cr
InventoryRs 270 Cr
Other liabilitiesRs 141 Cr
Shares outstanding (crore)1.65
Ownership
Promoter holding44.57% (-4.36 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 50.4 is at the 49th percentile of its own 9.3-year range
(median 50.4, low 13.5, high 313.0).
P/B 8.04 is at the 71th percentile (median 6.01).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | FREDUN | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -0.4% | -2.8% | +2.4 pts |
| 1 month | -9.5% | -6.8% | -2.7 pts |
| 3 years | +338.2% | +14.2% | +324.0 pts |
| 5 years | +655.5% | +27.9% | +627.6 pts |
Red flags
F-score 5 of 8| explain | Weak cash conversion Cash from operations was -7% of net profit over the last 3 years |
| look | Share dilution Share count up 15% in a year, 21% in three |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹228 Cr +90.0% vs Jun 2025.
Net profit ₹13 Cr +85.7%.
Against our estimate for Jun 2026: sales +33.9%, profit +26.7% beat. Our estimate for Sep 2026: sales Rs 230 Cr, profit Rs 14 Cr (how).
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Fredun Pharmaceuticals Ltd?
Fredun Pharmaceuticals Ltd (FREDUN) has a market capitalisation of Rs 2,301 Cr. at the 2026-10-01 close.
What is the P/E ratio of Fredun Pharmaceuticals Ltd?
Fredun Pharmaceuticals Ltd trades at a P/E of 51.8 on trailing twelve-month profit, at the 2026-10-01 close.
What were Fredun Pharmaceuticals Ltd's latest quarterly results?
In the Jun 2026 quarter, Fredun Pharmaceuticals Ltd sales was Rs 228 Cr (+90.0% vs Jun 2025) and net profit was Rs 13 Cr.
What is the 52-week high and low of Fredun Pharmaceuticals Ltd?
The 52-week high is Rs 1,590.00 and the 52-week low is Rs 1,195.20.